MORE VALSARTAN PRODUCTS RECALLED BY MHRA

The pharmaceutical journal Group

首页> 外文期刊>The pharmaceutical journal >MORE VALSARTAN PRODUCTS RECALLED BY MHRA

【24h】

MORE VALSARTAN PRODUCTS RECALLED BY MHRA

机译：更多的Valsartan产品由MHRA召回

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

A further product recall for heart and blood pressure drug valsartan has been issued by the Medicines and Healthcare products Regulatory Agency.

机译：用于心脏和血压药物Valsartan的进一步产品召回已由药物和医疗保健制品监管机构发布。

著录项

来源
《The pharmaceutical journal》 |2018年第7920期|共1页
作者
The pharmaceutical journal Group;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类药学;
关键词

相似文献

外文文献
中文文献
专利

1. MORE VALSARTAN PRODUCTS RECALLED BY MHRA [J] . The pharmaceutical journal Group The pharmaceutical journal . 2018,第7920期

机译：更多的Valsartan产品由MHRA召回
2. MHRA issues alert but Clexane will not be recalled [J] . The Pharmaceutical Journal Group The pharmaceutical journal . 2008,第7500期

机译：MHRA发出警报，但不会召回Clexane
3. Isolation and Characterization of Novel Degradation Products of Valsartan by NMR and High Resolution Mass Spectroscopy: Development and Validation of Valsartan by UPLC [J] . Kasani Kumaraswamy, Hima Bindu Gandham, Rudrakshula J.D. Prasad Asian Journal of Chemistry: An International Quarterly Research Journal of Chemistry . 2020,第5期

机译：NMR和高分辨率质谱的缬沙坦新型降解产物的分离与表征：UPLC缬沙坦的开发与验证
4. Consumer electronics recall support system by search of product user and improvement of recall notice [C] . Miyata Hiroki, Inoue Masahiro 2011 IEEE 15th International Symposium on Consumer Electronics . 2011

机译：通过搜索产品用户和改进召回通知的消费类电子产品召回支持系统
5. Climbing out of the hole or digging deeper: A model of customer reactions to product recalls and recalling firm responses. [D] . Steinbach, Adam Louis. 2016

机译：从漏洞中爬出或深入研究：客户对产品召回和召回公司响应的反应模型。
6. Risk-adapted approaches to the management of clinical trials: guidance from the Department of Health (DH)/Medical Research Council(MRC)/Medicines and Healthcare Products Regulatory Agency (MHRA) Clinical Trials Working Group [O] . Sarah Meredith, Martyn Ward, Gillian Booth, 2011

机译：适应风险的临床试验管理方法：卫生部（DH）/医学研究理事会（MRC）/药物和保健产品监管局（MHRA）临床试验工作组的指导
7. Risk-adapted approaches to the management of clinical trials: guidance from the Department of Health (DH)/Medical Research Council(MRC)/Medicines and Healthcare Products Regulatory Agency (MHRA) Clinical Trials Working Group [O] . Meredith Sarah, Ward Martyn, Booth Gillian, 2011

机译：适应风险的临床试验管理方法：卫生部（DH）/医学研究理事会（MRC）/药物和保健产品监管局（MHRA）临床试验工作组的指导
8. Letter to Providing Contact Information for the Consumer Product Safety Commission (CPSC) so that EPA can Review the Contents of Various Product Removal Reports on Individually Recalled Items Related to Lead and/or Phthalate Contamination with Di-n-octyl [R] . 2009

机译：致消费者产品安全委员会（CpsC）提供联系信息的信函，以便Epa可以审查关于用二正辛基引起的与铅和/或邻苯二甲酸盐污染有关的个别召回物品的各种产品清除报告的内容

MORE VALSARTAN PRODUCTS RECALLED BY MHRA

摘要

著录项

相似文献

相关主题

期刊订阅